Back to search

University of South Florida

Targeting Cancer with T Cells: Preclinical and In Silico Insights to Improve Immunotherapies

Abstract

dc:description

T-cell–based immunotherapies are often constrained by limited trafficking and persistence in tumors and by functional exhaustion under chronic antigen exposure. This dissertation addresses these barriers through two distinct strategies: (i) preclinical studies testing how radiation therapy modulates tumor-infiltrating lymphocytes (TIL) therapy, and (ii) agent based modeling (ABM) to optimize treatment day treatment-free intervals (TFI) in T-cell engager (TCE) therapy. (i) In a human papillomavirus–positive (HPV⁺) head-and-neck cancer (HNC) model, a single local-dose of RT (8 Gy) delivered five days before tumor harvest increased the success and functional quality of ex vivo TIL outgrowth from tumor fragments, enriching polyfunctional CD8⁺ subsets. Delivering the same dose on the day of adoptive cell transfer (ACT) enhanced intratumoral accumulation of antigen-specific adoptively transferred T cells, improved control of both irradiated and shielded tumors, and generated durable tumor memory. (ii) To optimize TCE therapy in a B-cell acute lymphoblastic leukemia (B-ALL) setting, an ABM calibrated to published TCE data reproduced the reported advantage of a 7-day TFI over continuous exposure after 28 days, but showed that this advantage dissipates across a full 42-day clinical treatment cycle. Model-guided exploration of dosing schedules identified shorter, more frequent TFIs as superior for sustaining effector function and tumor control while limiting T cell exhaustion. Together, this work provides experimental and computational insights that may help refine the design of future T-cell–based therapies.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (Ph.D.)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Molecular Biosciences
Grantor
University of South Florida
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Obertopp, Nina
Contributors dc:contributor
  • Shari Pilon-Thomas, Ph.D.
  • Daniel Abate-Daga, Ph.D.
  • Dorina Avram, Ph.D.
  • Lawrence L. Stern, Ph.D.
  • Sungjune Kim, M.D., Ph.D.

Subjects

dc:subject × 8

Identifiers

dc:identifier.*
Repository record dc:identifier
https://digitalcommons.usf.edu/etd/11375

Chain of custody

source
Harvested from
University of South Florida
Base URL
digitalcommons.usf.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Obertopp, Nina. Targeting Cancer with T Cells: Preclinical and In Silico Insights to Improve Immunotherapies. Dissertation thesis, University of South Florida, 2026. https://digitalcommons.usf.edu/etd/11375